Patients treated with sulfonylureas (p = 0.008), insulin and metformin association (p = 0.040), insulin and sulfonylurea association (p = 0.048), and DPP4i and sulfonylurea association (p = 0.031) were exposed to a higher risk of hyperglycemia (≥180 mg/dL) at admission (Table 5). The gene discussed is INS; the disease is Hyperglycemia.